January 22, 2024
Jaime Yassif is the Nuclear Threat Initiative’s vice president for Global Biological Policy and Programs and this month’s Professional in Residence at QB3-Berkeley. Yassif spoke to graduate student Sita Chandrasekaran ahead of her January 25th visit to campus. Bioscience trainees are welcome to register for Yassif’s events. Sita Chandrasekaran: Could you tell us about your…
November 30, 2023
Arne Bakker, PhD, is the director of Meetings and Community for Science at Chan Zuckerberg Initiative. The QB3-Berkeley Professionals in Residence program will be joined by Bakker on Friday, December 8th. UC Berkeley and LBL trainees may register for Bakker’s events here. Bakker spoke with graduate student Santiago Yori Restrepo about his journey in science…
April 18, 2023
Bilge Ozaydin is the Director of the Strain Discovery and Development group at Pivot Bio. The QB3-Berkeley Professionals in Residence program will be joined by Ozaydin on Friday, May 5th. UC Berkeley and LBL trainees may register for Ozaydin’s events here. Ozaydin spoke with postdoctoral researcher Briana Van Treeck about her scientific journey. Briana Van…
January 11, 2023
Miki Yamamoto, PhD, is the vice president and head of regulatory affairs at Arrivent Biopharma. Yamamoto is joining the QB3-Berkeley Professionals in Residence (PIR) program on February 9th 2023. UC Berkeley and LBL trainees may register for Yamamoto’s events here. Yamamoto spoke with graduate student Anneliese Gest about her journey in regulatory affairs. Anneliese Gest:…
November 15, 2022
Katja Brose, PhD, is a science program officer at the Chan Zuckerberg Initiative (CZI). Brose is joining the QB3-Berkeley Professionals in Residence (PIR) program on January 26th, 2023. UC Berkeley trainees may register for Brose’s PIR events here. Brose spoke with graduate student Samvardhini Sridharan about her career and the opportunities she’s had to wear…
April 26, 2022
Seth Lieblich, PhD, is a principal at venture capital firm 8VC focusing on life sciences technologies. He joins the QB3-Berkeley Professional in Residence program on May 6th. Lieblich spoke to postdoctoral researcher Elisabeth Gill about his trajectory from academic research to the biotech entrepreneurship ecosystem working in a biotech start-up, consulting, within the business development…
March 29, 2022
Timothy Day, PhD and UC Berkeley alumnus, is the co-founder and chief scientific officer (CSO) of DNALite Therapeutics. Day will be QB3-Berkeley’s Professional in Residence on April 5, 2022. In an interview with graduate student Leah Gulyas, Day traced his path to entrepreneurship from growing up in Kansas with the goal of pursuing medicine to…
February 03, 2022
Christine Ring, PhD, JD, is the secretary of Nurix and the company’s general counsel. Ring is joining the QB3-Berkeley Professionals in Residence (PIR) program on Friday, Feburary 11th for two in-person events in Stanley Hall on the UC Berkeley campus. Interested graduate students and postdocs may register for Ring’s events here. Ring spoke with graduate…